Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cost-effectiveness of domestic vs imported levetiracetam in children with focal epilepsy
ChiCTR2200057041Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levetiracetam in Focal Onset Epilepsy (2 arms), sponsored by Beijing Children's Hospital. Primary endpoints: Evaluation of clinical efficacy, Clinical safety observation and 2 more. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on ChiCTR2200057041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057041.